Aim and Scope...


Journal of Hematology and Oncology Forecast to enhance the free scientific knowledge to the worldwide readers and unlimited free access to the readers. Journal considers research manuscripts, review manuscripts, editorials, commentaries, opinion pieces, case studies, case reports, clinical images, letters and perspectives. Editorials, perspectives and opinions are submitted by authors and editorial board members on topics pertaining to hematology and oncology. Journal content will be published on a continuous publication model.

Journal of Hematology and Oncology Forecast manuscripts undergo double blinded peer-review process where each manuscript undergoes evaluation by our editors, if appropriate, is reviewed by a minimum of three independent reviewers. The average time between submission and final decision is 15-25 days and the average time between acceptance and publication is 10-15 days. We publish manuscripts in HTML, PDF and XML format and all articles published by journal are freely accessible to everyone immediately after publication.


Journal of Hematology and Oncology Forecast scope covers in all areas related to hematology and oncology aspects such as Anatomical Pathology Anemias Anti-Cancer Chemotherapy Anticoagulation Therapy Blood Blood Bank Blood Donors Blood Groups Blood Plasma Blood Tests Blood Transfusion Bone Marrow Bone Marrow Transplant Coagulation Coagulopathies Complement System Cord Blood Erythropoiesis Erythropoietin Experimental Cancer Treatment Fertility Preservation Glycolysis Gynecologic Oncology Hematological Malignancies Hematopoiesis Hemoglobin Hemostasis Intramuscular Injections Iron Metabolism Liver Lymphatic System Medical Oncology Ocular Oncology Oncofertility Palliative Care Pediatric Oncology Pentose Phosphate Pathway Performance Status Platelets Psycho-Oncology Radiation Oncology Radiology Radiotherapy Red Blood Cells Reticulo-endothelial System Sickle Cell Anemia Spleen Surgical Oncology Thalassemia Tumor Bank Venesection Venipuncture Venous Blood Vitamin K White Blood Cells Cancer Immunology Immunotherapy